Open AccessNeutrophlic dermatosis (Sweet's syndrome‐like) induced by paracetamol
Author(s) -
Culla M Teresa Dordal,
Amayuelas Ramon Navarra,
DiezCanseco M Teresa MartinUrda,
FernandezFigueras M Teresa,
Giralt Carles Lucas,
Vazquez M Mercedes Gomez
Publication year - 2014
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-4-s3-p83
Subject(s) - medicine , malaise , neutrophilia , myalgia , dermatology , surgery , eosinophilia , decongestant , drug eruption , anesthesia , drug , antihistamine , psychiatry
Case-report An 82 year-old man with hypertension and ischemic heart disease underwent an inguinal hernioplasty. Twenty hours after initiating PC administration in the surgery room, a slightly pruritic eruption suddenly appeared with multiple tender, oedematous and erythematous plaques on the trunk and extremities, associated to general malaise, headache and myalgia. He didn’t seek for medical care until 1 week later, when he came to the hospital for suture removal. No treatment was prescribed and the eruption resolved in 4 weeks. Two months later the patient developed, once again, a similar generalized skin eruption with fever (38.5oC), general malaise and weakness. Neutrophilia (88.6%) and elevated C-reactive protein levels were detected. There was no mucosal or extracutaneous involvement. Few hours previously he had taken PC for a mild non-pyretic upper respiratory tract infection. The drug was withdrawn, and all signs and symptoms resolved after a short course of corticosteroid treatment. No evidence of active infection was detected. Histological examination of a skin biopsy specimen showed a neutrophilic infiltrate with mild eosinophilia, neutrophilic spongiosis and lichenoid damage. Five months later we performed epicutaneous patch test with PC in unaffected and previously affected skin, with negative results. The patient refused to perform more allergic studies. He had been tolerating ibuprofen, metamizole and acetylsalicylic acid after the last reaction. Neither new episodes nor evidence of malignancy have been detected in the meantime.